Sotera Health price target raised to $23 from $21 at Citi

Citi raised the firm’s price target on Sotera Health (SHC) to $23 from $21 and keeps a Buy rating on the shares. The company established FY26 guidance calling for total revenue growth of 5%-6.5%, which translates to $1.233B-$1.251B, and an adjusted EPS midpoint of 97c, slightly above expectations, the analyst tells investors. Management took “a prudent approach” in the guidance, the analyst added.